title: Esophagitis Dissecans Superficialis Endoscopically Induced in a Patient With Pemphigus Vulgaris and Gastrointestinal Complaints.
authors.affiliation: University of North Dakota School of Medicine, Grand Forks.
authors.forename: Taylor
authors.initials: T
authors.lastname: Braunberger
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City.
authors.forename: Jason E
authors.initials: JE
authors.lastname: Hawkes
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City.
authors.forename: Jennie T
authors.initials: JT
authors.lastname: Clarke
authors.affiliation: Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Utah, Salt Lake City.
authors.forename: Kathleen K
authors.initials: KK
authors.lastname: Boynton
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City.
authors.forename: Kristin M
authors.initials: KM
authors.lastname: Leiferman
mesh_terms: D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D016145:Endoscopy, Digestive System / Q000009:adverse effects* / Q000379:methods; D004941:Esophagitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D009173:Mycophenolic Acid / Q000008:administration & dosage; D010392:Pemphigus / Q000150:complications / Q000175:diagnosis*; D011239:Prednisolone / Q000008:administration & dosage; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D011239:Prednisolone; D009173:Mycophenolic Acid